Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 23/10/2019

Debbie Rigby rounds up the latest in research news Safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis This small study (n=111) assessed the safety, tolerability and efficacy of palmitoylethanolamide (PEA) when dosed at 300 mg and 600 mg per day on symptoms of knee osteoarthritis. The results showed significant reductions in pain,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Research Roundup

Previous Appeal for more meds monitoring

Next Aged care antimicrobials up

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Appeal for more meds monitoring

Next Aged care antimicrobials up

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.